This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LeadingBiotech: Cancer Advance
March 5, 2020
Koch Institute for Integrative Cancer Research at MITCambridge, MA

Michael Ciarametaro
VP of Research at National Pharmaceutical Council


Michael Ciarametaro serves as the National Pharmaceutical Council's vice president of research. In this position, Mr. Ciarametaro plays a key role in developing and delivering NPC’s portfolio of health policy and health outcomes projects.

Mr. Ciarametaro has 13 years of health care industry experience with both pharmaceutical manufacturers and payers. Most recently, he was a senior research manager at Evidera, where he designed and led a wide variety of both qualitative and quantitative studies across multiple health care industries and stakeholders. Mr. Ciarametaro’s work analyzed reimbursement and treatment patterns for drugs, biologicals and devices. Prior to Evidera, he served as a financial analysis manager at WellPoint NextRx and as lead staff at Noblis, a nonprofit science, technology and strategy organization.

Mr. Ciarametaro holds a Bachelor of Science from the University of Virginia and received his MBA from George Mason University.

Agenda Sessions

  • Pricing of Oncology Drugs